Valsartan premium pharma 80 mg comprimidos recubiertos con pelicula efg
Introduction
Product Information for the Patient
Valsartan Premium Pharma 80 mg Film-Coated Tablets.
valsartan
Read this entire product information carefully before starting to take this medication, as it contains important information for you.
- Keep this product information, as you may need to refer to it again.
- If you have any questions, consult your doctor or pharmacist.
- This medication has been prescribed only for you and should not be given to others, even if they have the same symptoms as you, as it may harm them.
- If you experience any adverse effects, inform your doctor or pharmacist, even if they are not listed in this product information. See section 4.
1. What is Valsartán Premium Pharma and what is it used for
Valsartán Premium Pharma belongs to a class of medications known as angiotensin II receptor antagonists, which help control high blood pressure. Angiotensin II is a substance in the body that causes blood vessels to constrict, resulting in increased blood pressure. Valsartán Premium Pharma acts by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure decreases.
Valsartán Premium Pharma 80 mg film-coated tabletscan be used to treat three different conditions:
- to treat high blood pressure in adults and in children and adolescents aged 6 to 18 years.High blood pressure increases the workload of the heart and arteries. If left untreated, it can damage blood vessels in the brain, heart, and kidneys, and may cause a stroke, heart failure, or kidney failure. High blood pressure increases the risk of heart attacks. Reducing blood pressure to normal values reduces the risk of developing these disorders,
- to treat adult patients after a recent heart attack(myocardial infarction). “Recent” means here between 12 hours and 10 days,
to treat symptomatic heart failure in adult patients.Valsartan Premium Pharma is used when it is not possible to use a group of medications called angiotensin-converting enzyme inhibitors (ACE inhibitors) (a medication to treat heart failure), or it may be used in addition to ACE inhibitors when it is not possible to use other medications for the treatment of heart failure. Among the symptoms of heart failure are difficulty breathing and swelling of feet and legs due to fluid retention. This is because the heart muscle is not able to pump blood with sufficient force to provide all the blood needed by the body.
2. What you need to know before starting Valsartán Premium Pharma
Do not take Valsartán Premium Pharma:
- if you areallergic(hypersensitive) to valsartán or to any of the other components of this medication (listed in section 6).
- if you have aserious liver disease,
- if you aremore than 3 months pregnant(it is better to avoid Valsartán Premium Pharma during the first months of pregnancy – see Pregnancy section).
- if you have diabetes or kidney failure and are being treated with a medication to lower blood pressure that contains aliskirén.
If any of the above situations affect you, inform your doctor and do not take Valsartán Premium Pharma.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Valsartán Premium Pharma
- if you have a liver disease,
- if you have a serious kidney disease or if you are undergoing dialysis,
- if you have a narrowing of the kidney artery,
- if you have recently undergone a kidney transplant (you received a new kidney),
- if you have a serious heart disease other than heart failure or heart attack,
- if you have experienced swelling of the tongue and face caused by an allergic reaction called angioedema when taking other medications (including ACEIs), inform your doctor. If you have these symptoms when taking Valsartan Premium Pharma, stop taking it immediately and never take it again. See also section 4 “Possible side effects”.
- if you are using medications that increase the amount of potassium in the blood. These include potassium supplements or salt substitutes that contain potassium, potassium-sparing medications, and heparin. You may need to regularly control the amount of potassium in the blood,
- if you have aldosteronism, a disease in which the adrenal glands produce too much aldosterone hormone. In this case, it is not recommended to take Valsartán Premium Pharma,
- if you have lost a lot of fluid (dehydration) due to diarrhea, vomiting, or high doses of diuretics (medications to increase urine production),
- if you are taking any of the following medications used to treat high blood pressure:
- a medication that blocks the angiotensin-converting enzyme (ACEI) (such as enalapril, lisinopril, ramipril), especially if you have kidney problems related to diabetes
- aliskirén
- if you are being treated with an ACEI along with other medications specifically used to treat your heart failure, known as mineralocorticoid receptor antagonists (MRAs) (such as spironolactone, eplerenone) or beta-blockers (such as metoprolol).
Your doctor may regularly check your kidney function, blood pressure, and electrolyte levels (such as potassium) in the blood.
See also the information under the heading “Do not take Valsartán Premium Pharma”.
- You should inform your doctor if you think you are or may be pregnant. Valsartan Premium Pharma is not recommended at the beginning of pregnancy, and it should not be taken if you are more than three months pregnant, as it may cause serious harm to your baby if used during this period (see Pregnancy section).
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking valsartán. Your doctor will decide whether to continue treatment. Do not stop taking valsartán in monotherapy.
Other medications and Valsartán Premium Pharma
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
The effect of treatment with Valsartán Premium Pharma may be altered if taken with certain medications. Your doctor may need to adjust your dose and/or take other precautions or, in some cases, stop treatment with one of the medications. This applies to both prescription and non-prescription medications, especially:
- other medications that lower blood pressure,especiallydiuretics(medications to increase urine production),ACEIs(such as enalapril, lisinopril, etc.), oraliskirén(see also the information under the headings “Do not take Valsartán Premium Pharma” and “Warnings and precautions”).
- medications that increase the amount of potassiumin the blood. These include potassium supplements or salt substitutes that contain potassium, potassium-sparing medications, and heparin,
- certain medications used to treat paincalled nonsteroidal anti-inflammatory drugs (NSAIDs),
- someantibiotics (in the group of rifampicin), a medication used to protect against rejection in a transplant (ciclosporina) or a medication antiretroviral used to treat HIV/SIDA infection (ritonavir). These medications may increase the effect of valsartan.
- litium,a medication used to treat certain types of psychiatric diseases.
Additionally:
- if you are being treated aftera heart attack,it is not recommended to combine withACEIs(a medication to treat a heart attack),
- if you are being treated forheart failure,it is not recommended to take a triple combination withACEIs and other medications specifically used to treat your heart failure,known as mineralocorticoid receptor antagonists (MRAs) (such as spironolactone, eplerenone) or beta-blockers (such as metoprolol).
Pregnancy and breastfeeding
- Pregnancy
You should inform your doctor if you are pregnant (or if you suspect you may be).Your doctor will generally recommend that you stop taking Valsartán Premium Pharma before becoming pregnant or as soon as you know you are pregnant and recommend that you take another medication instead of Valsartán Premium Pharma. Valsartán Premium Pharma is not recommended at the beginning of pregnancy, and it should not be taken if you are more than three months pregnant, as it may cause serious harm to your baby if used during this period.
- Breastfeeding
Inform your doctor if you are breastfeeding or are about to start.It is not recommended to use Valsartán Premium Pharma during breastfeeding, and your doctor will choose another treatment for you if you want to breastfeed, especially if your baby is newborn or premature.
Driving and operating machinery
Before driving a vehicle, using tools, or operating machines, or performing other activities that require concentration, make sure you know how Valsartán Premium Pharma affects you. Like many other medications used to treat high blood pressure, Valsartán Premium Pharma may cause, in rare cases, dizziness and affect concentration.
3. How to take Valsartán Premium Pharma
Adult patients with high blood pressure:The usual dose is 80 mg per day. In some cases, your doctor may prescribe higher doses (e.g. 160 mg or 320 mg). You may also take Valsartán Premium Pharma with another medication (e.g. a diuretic).
Use in children and adolescents (6 to less than 18 years of age) with high blood pressure
In patients weighing less than 35 kg, the usual dose is 40 mg of valsartán once a day.
In patients weighing 35 kg or more, the usual starting dose is 80 mg of valsartán once a day.
In some cases, your doctor may prescribe higher doses (the dose may be increased to 160 mg and up to a maximum of 320 mg).
Adult patients after a recent heart attack:After a heart attack, treatment usually starts at 12 hours, usually with a low dose of 20 mg, administered twice a day. The 20 mg dose is obtained by dividing the 40 mg tablet. Your doctor will gradually increase this dose over several weeks to a maximum of 160 mg twice a day. The final dose will depend on your individual tolerance.
Valsartán Premium Pharma can be taken with other treatments for heart attack, and your doctor will decide what treatment is suitable for you.
Adult patients with heart failure:Treatment usually starts with 40 mg twice a day. Your doctor will gradually increase the dose over several weeks to a maximum of 160 mg twice a day. The final dose will depend on your individual tolerance.
Valsartán Premium Pharma can be taken with other treatments for heart failure, and your doctor will decide what treatment is suitable for you.
You can take valsartán with or without food. Swallow valsartán with a glass of water.
Take valsartán approximately at the same time every day.
Uncovered dosage with the available presentations of Valsartán Premium Pharma
The available presentations of Valsartán Premium Pharma (80 mg, 160 mg, and 320 mg) do not allow for the administration of the recommended starting dose for the treatment of recent myocardial infarction or heart failure in adults, or for the treatment of hypertension in children <35>.
If you take more Valsartán Premium Pharma than you should
If you experience severe dizziness and/or fainting, contact your doctor immediately and lie down. If you have accidentally taken too many tablets, contact your doctor, pharmacist, or hospital. You can also call the Toxicology Information Service, phone 91-562 04 20, indicating the medication and the amount taken.
If you forget to take Valsartán Premium Pharma
If you forget to take a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose.
Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Valsartán Premium Pharma
If you stop taking Valsartán Premium Pharma, your condition may worsen. Do not stop taking the medication unless your doctor tells you to.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
4. Possible Adverse Effects
Some side effects may be serious and may require immediate medical attention:You may experience symptoms of angioedema (a specific allergic reaction), such as
- swelling in the face, lips, tongue, or throat,
- difficulty breathing or swallowing,
- hives, itching.
Side effects include:
Frequent(may affect up to 1 in 10 people):
- dizziness,
- low blood pressure with or without symptoms such as dizziness and fainting when standing up,
- reduced kidney function (signs of renal deterioration).
Rare(may affect up to 1 in 100 people):
- angioedema (see section “Some symptoms require immediate medical attention”)
- sudden loss of consciousness (syncope),
- sensation of spinning (vertigo),
- marked reduction in kidney function (signs of acute renal insufficiency),
- muscle spasms, abnormal heart rhythm (signs of hyperkalemia),
- shortness of breath, difficulty breathing while lying down, swelling of the feet or legs (signs of heart failure),
- headache,
- cough,
- abdominal pain,
- nausea,
- diarrhea,
- fatigue,
- weakness.
Very rare(may affect up to 1 in 10,000 people)
- Intestinal angioedema: swelling in the intestine that presents symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Frequency not known(cannot be estimated from available data):
- blistering on the skin (sign of pemphigus)
- may occur allergic reactions with skin rash, itching, and hives; symptoms of serum sickness, such as fever, swelling, and joint pain, muscle pain, swelling of lymph nodes, and/or symptoms similar to the flu,
- red-purple spots, fever, itching (signs of vasculitis),
- more frequent bleeding or bruising than usual (signs of thrombocytopenia),
- muscle pain (myalgia),
- fever, sore throat, or ulcers in the mouth due to infections (symptoms of low white blood cell count, also called neutropenia),
- reduction in hemoglobin level and reduction in percentage of red blood cells in the blood (which, in severe cases, may cause anemia),
- increase in potassium level in the blood (which, in severe cases, may cause muscle spasms and abnormal heart rhythm),
- elevation of liver function values (which may indicate liver damage), including an increase in bilirubin level in the blood (which, in severe cases, may cause the skin and eyes to turn yellow),
- increase in urea nitrogen level in the blood and increase in serum creatinine level (which may indicate renal anomalies).
- low sodium level in the blood (which, in severe cases, may cause fatigue, confusion, muscle fasciculations, and/or convulsions)
The frequency of some side effects may vary depending on your condition. For example, certain side effects such as dizziness and reduced kidney function were observed less frequently in adult patients treated for high blood pressure than in adult patients treated for heart failure or after a recent heart attack.
Side effects in children and adolescents are similar to those observed in adults.
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:http://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
5. Conservation of Valsartán Premium Pharma
- Store below 30°C. Store in the original packaging to protect it from moisture.
- Keep out of the reach and sight of children.
- Do not use this medication after the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
- Do not use Valsartán Premium Pharma if you observe that the packaging is damaged or shows signs of manipulation.
- Medicines should not be thrown down the drains or in the trash. Dispose of the packaging and unused medicines at the SIGRE collection point of your usual pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
6. Additional Information
Composition of Valsartán Premium Pharma
- The active ingredient is valsartan.
- A film-coated tablet contains 80 mg of valsartan.
- The other components are microcrystalline cellulose, crospovidone, and magnesium stearate.
- The tablet coating contains hypromellose, titanium dioxide (E171), macrogol PGE 8000, red iron oxide (E172), and yellow iron oxide (E172).
Appearance of the product and contents of the package
Valsartán Premium Pharma 80 mg film-coated tablets are pink, round, and scored on one side. The tablet can be divided into two equal halves.
The tablets are presented in blister packs containing 28 tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Premium Pharma SL
Avda. de Bruselas, 13. 3ºD.
28108 Alcobendas (Madrid)
Spain
Responsible for manufacturing
Atlantic Pharma - Produções Farmacêuticas, S.A.
Rua da Tapada Grande, nº2, Abrunheira
2710-089 Sintra
Portugal
Last review date of this leaflet: February 2025
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Поговоріть з лікарем онлайн
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.
